Durable rust resistance in wheat is effective against multiple pathogens

Tese de doutoramento em Ciências da Saúde, no ramo de Medicina Dentária, apresentada à Faculdade de Medicina da Universidade de CoimbraA osteonecrose maxilar associada aos bifosfonatos, que se apresenta como uma lesão pós-cirúrgica associada a incapacidade de cicatrização, é um dos efeitos secundários mais frequentemente observados nos doentes submetidos a terapêutica com bifosfonatos nitrogenados. Assim, esta patologia é diagnosticada maioritariamente em doentes com metastização óssea, sob terapêutica com bifosfonatos nitrogenados intra-venosos. A fisiopatologia da osteonecrose maxilar associada aos bifosfonatos tem sido relacionada com a supressão da remodelação óssea, com a infeção local e com a toxicidade dos bifosfonatos nos tecidos envolventes, que mantém e perpetua a exposição óssea. Os fatores de risco da osteonecrose maxilar associada aos bifosfonatos foram categorizados em fatores relacionados com a terapêutica, que incluem a administração intravenosa em doenças oncológicas e a utilização do bifosfonato mais potente, o zoledronato; e factores locais, que incluem as exodontias, a colocação de implantes, a cirurgia periapical e a cirurgia periodontal que envolva os tecidos ósseos. No entanto, no caso da cirurgia periapical, não foram encontrados estudos que relacionem este procedimento com a osteonecrose maxilar. No contexto da toxicidade do zoledronato, uma vez que os compostos de fosfato de cálcio têm a capacidade de o adsorver, nomeadamente quando utilizados como sistemas transportadores de bifosfonatos, e são passíveis de aplicação nas locas cirúrgicas, constituindo substitutos ósseos adequados, colocou-se a hipótese de estes compostos poderem, potencialmente, ter um efeito protetor nos tecidos que envolvem as locas cirúrgicas. Assim, constituíram objetivos deste trabalho a avaliação da cirurgia periapical como desencadeadora de osteonecrose maxilar na presença de zoledronato e, paralelamente, a avaliação do potencial protetor da aplicação de compostos de fosfato de cálcio na loca cirúrgica. Para cumprir os objetivos propostos neste trabalho, realizaram-se estudos de química, estudos in vitro e estudos in vivo. No que respeita aos estudos de química, avaliou-se a reação entre o zoledronato e os compostos de fosfato de cálcio. Através de espetroscopia do visível e de análise elementar, verificou-se que o zoledronato é adsorvido, em solução aquosa, pelos compostos bifásicos de fosfato de cálcio. A etiologia da osteonecrose maxilar descreve um efeito deletério dos bifosfonatos nos tecidos moles, especialmente nos fibroblastos, que apresentam uma função insubstituível na cicatrização das lesões cirúrgicas orais. No contexto dos estudos in vitro, estabeleceram-se culturas primárias de fibroblastos gengivais humanos, que constituíram um modelo para avaliar a citotoxicidade na presença de zoledronato e na presença da associação zoledronato/compostos bifásicos de fosfato de cálcio. Avaliou-se a atividade metabólica dos fibroblastos gengivais humanos através do ensaio de MTT (brometo de 3-(4,5-dimetiltiazol-2-il)-2,5-difeniltetrazol), a sua viabilidade através do ensaio de SRB (ensaio da sulforrodamina B), os tipos de morte e o ciclo celular dos fibroblastos gengivais humanos através de citometria de fluxo e a capacidade de migração através do scratch assay. Verificou-se que o zoledronato apresentou um efeito citotóxico significativo nos fibroblastos gengivais humanos, com diminuição da atividade metabólica e da viabilidade, com aumento das populações celulares em morte por apoptose e por necrose e pela diminuição da capacidade de migração. Com a associação zoledronato/compostos bifásicos de fosfato de cálcio, foi possível diminuir, ou mesmo anular, a toxicidade do zoledronato, que se manifestou pela ausência de diferenças em relação aos grupos controlo. Nos estudos in vivo, foi utilizado um modelo experimental reprodutível já estudado, que relaciona diretamente a administração crónica de bifosfonatos com o desenvolvimento de osteonecrose maxilar após exodontia. Este modelo animal serviu como base ao desenvolvimento de um modelo de cirurgia apical com administração crónica de bifosfonatos. Os grupos de animais tratados foram submetidos a administração intra-peritoneal de zoledronato nas quatro semanas antecedentes à intervenção cirúrgica e nas duas ou três semanas seguintes. As mandíbulas foram avaliadas macroscopicamente, através da medicina nuclear, radiologia e histologia. No contexto da medicina nuclear, foi utilizado o radiofármaco 99mTc-zoledronato, que foi obtido após o desenvolvimento e a optimização de um procedimento de marcação radioquímica do zoledronato, e respetivo controlo de qualidade. Verificou-se que, nos animais submetidos à terapêutica com zoledronato, em que se desenvolveu a exodontia, existiu maior captação de 99mTc-zoledronato, menor densidade radiográfica e alterações histológicas compatíveis com cicatrização diminuída. Com a aplicação dos compostos bifásicos de fosfato de cálcio, não se observaram diferenças em relação aos animais controlo. No caso dos animais submetidos à cirurgia apical, não se verificaram alterações significativas em relação aos animais controlo, nos animais submetidos à terapêutica com zoledronato, tanto na presença como na ausência da aplicação de compostos bifásicos de fosfato de cálcio. Este trabalho de investigação permitiu elucidar acerca dos desígnios que deram origem a esta tese. No modelo animal de cirurgia periapical desenvolvido, não foi observado um atraso significativo da cicatrização nem sinais da osteonecrose maxilar, nos tempos avaliados, concluindo-se que a terapêutica com zoledronato poderá não constituir um fator de risco nesta intervenção cirúrgica. Pelo contrário, no modelo animal de exodontia confirmou-se que, efetivamente, o zoledronato constitui um fator de risco, e que os compostos bifásicos de fosfato de cálcio, apresentam potencial efeito protetor da toxicidade inerente aos bifosfonatos. Esta conclusão foi sustentada pelos estudos de química, em que se verificou a adsorção do zoledronato, corroborada por supressão da toxicidade nos estudos in vitro e cicatrização favorecida no modelo animal de exodontia com administração crónica de zoledronato.Bisphosphonate-associated osteonecrosis of the jaw, a post-surgical non-healing wound condition, is one of the most often seen side effects in patients treated with nitrogencontaining bisphosphonates. Therefore, this pathology is primarily diagnosed in patients with metastatic bone disease, receiving intravenous administration of nitrogen-containing bisphosphonates. Bisphosphonate-associated osteonecrosis of the jaw physiopathology has been related with suppression of bone turnover, local infections or soft tissue toxicity. Recent studies associate the physiopathological mechanisms of the osteonecrosis of the jaw with toxic effects of bisphosphonates on different cell types, besides osteoclast, being the most important cause of soft tissues toxicity that contributes for the maintenance of bone exposure. Bisphosphonate-associated osteonecrosis of the jaw risk factors were categorized as drug-related factors, including intravenous administration in oncological diseases and the use of the most potent bisphosphonate, zoledronate; and local factors including, dental extractions, dental implant placement, periapical surgery and periodontal surgery involving osseous injury. However, there are no studies that relate periapical surgery with osteonecrosis of the jaw. Considering zoledronate toxicity, since calcium phosphate compounds are able to adsorb it, namely when used as drug delivery vehicle, and are also used in surgical wounds, as a bone substitute, it was hypothesised this compounds had a potential protective effect to the soft tissues surrounding surgical osseous wounds. Thus, the aim of this study was to assess periapical surgery as a trigger of osteonecrosis of the jaw in the presence of zoledronate and also the potential protective effect of calcium phosphate compounds when applied in the surgical wound. To fulfil the proposed objectives of this work were carried out studies of chemistry, in vitro and in vivo studies. Regarding chemical studies, it was evaluated the chemical reaction between zoledronate and calcium phosphate compounds. Through ultraviolet-visible spectroscopy and elemental analysis it has been found that zoledronate, in aqueous solution, was adsorbed by biphasic calcium phosphate compounds. Bisphosphonate-associated osteonecrosis of the jaw aetiology describes a deleterious effect of bisphosphonates on soft tissues, especially on fibroblasts, which play an important role in oral wound healing. Considering in vitro studies it was established a primary culture of human gingival fibroblasts that constituted a model to evaluate the cytotoxicity in the presence of zoledronate and of zoledronate/biphasic calcium phosphate compounds association. It was investigated the metabolic activity of human gingival fibroblasts through MTT (3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, cell viability through SRB (sulforhodamine B) assay, types of cell death and cell cycle through flow cytometry and migration ability of human gingival fibroblasts through scratch assay. It was verified that zoledronate had a strong cytotoxic effect in the human gingival fibroblasts, by the reduction of metabolic activity, cell viability, increase of cells in apoptosis and reduction of migration. With the association zoledronate/biphasic calcium phosphate compounds it was possible to reduce or abolish zoledronate toxicity, as it was demonstrated by the absence of differences related to control. In the in vivo study it was used a reproducible experimental model that directly relates chronic bisphosphonate administration with the development of osteonecrosis of the jaw with tooth extraction. This animal model also served as basis to the development of a osteotomy in periapical surgery model with chronic bisphosphonate administration. The animals were treated with zoledronate intraperitoneally, during the four weeks that preceded the surgeries and in the following two and three weeks. The mandibles were macroscopic evaluated, examined by nuclear medicine, radiology and histologically analysed. Concerning nuclear medicine it was used the radiopharmaceutical 99mTc-zoledronate, which was obtained after the development and optimization of a procedure for zoledronate radiochemical labelling, and respective quality control. It has been found that the animals with zoledronate, submitted to tooth extraction, had a higher 99mTc-zoledronate uptake, lower radiological density and histologic images compatible with a decreased healing. With biphasic calcium phosphate compounds application, there were no differences related to controls. In the animals submitted to osteotomy in periapical surgery there were no significant differences related to the controls, in both animals with zoledronate, with and without biphasic calcium phosphate compounds application. This research work allowed the clarification of the goals that led to this thesis. In the created animal model of osteotomy in periapical surgery, it was not observed a significant delay in the wound healing, neither osteonecrosis of the jaw, in the evaluated periods, therefore it was conclude that zoledronate therapeutic may not constitute a risk factor in this surgical approach. Contrarily, in the tooth extraction animal model, it was confirmed that zoledronate therapeutic constitute a risk factor, and it was found that biphasic calcium phosphate compounds presents a potential protector effect from bisphosphonates toxicity. This conclusion was supported by the chemical studies, in which it was observed adsorption of zoledronate, corroborated by the lower toxicity in the in vitro studies and by the improved cicatrisation in the tooth extraction animal model with chronic bisphosphonates administration

Wheat rusts never sleep but neither do sequencers: will pathogenomics transform the way plant diseases are managed?

Field pathogenomics adds highly informative data to surveillance surveys by enabling rapid evaluation of pathogen variability, population structure and host genotype

Isolation and fine mapping of Rps6: An intermediate host resistance gene in barley to wheat stripe rust

A plant may be considered a nonhost of a pathogen if all known genotypes of a plant species are resistant to all known isolates of a pathogen species. However, if a small number of genotypes are susceptible to some known isolates of a pathogen species this plant maybe considered an intermediate host. Barley (Hordeum vulgare) is an intermediate host for Puccinia striiformis f. sp. tritici (Pst), the causal agent of wheat stripe rust. We wanted to understand the genetic architecture underlying resistance to Pst and to determine whether any overlap exists with resistance to the host pathogen, Puccinia striiformis f. sp. hordei (Psh). We mapped Pst resistance to chromosome 7H and show that host and intermediate host resistance is genetically uncoupled. Therefore, we designate this resistance locus Rps6. We used phenotypic and genotypic selection on F2:3 families to isolate Rps6 and fine mapped the locus to a 0.1 cM region. Anchoring of the Rps6 locus to the barley physical map placed the region on two adjacent fingerprinted contigs. Efforts are now underway to sequence the minimal tiling path and to delimit the physical region harbouring Rps6. This will facilitate additional marker development and permit identification of candidate genes in the region

Latent class analysis of sexual health markers among men and women participating in a British probability sample survey.

BACKGROUND: Despite known associations between different aspects of sexual health, it is not clear how patterning of adverse sexual health varies across the general population. A better understanding should contribute towards more effective problem identification, prevention and treatment. We sought to identify different clusters of sexual health markers in a general population, along with their socio-demographic, health and lifestyle correlates. METHODS: Data came from men (N = 5113) and women (N = 7019) aged 16-74 who reported partnered sexual activity in the past year in Britain's third National Survey of Sexual Attitudes and Lifestyles, undertaken in 2010-2012. Latent class analysis used 18 self-reported variables relating to adverse sexual health outcomes (STI and unplanned pregnancy, non-volitional sex, and sexual function problems). Correlates included socio-demographics, early debut, alcohol/drug use, depression, and satisfaction/distress with sex life. RESULTS: Four classes were found for men (labelled Good Sexual Health 83%, Wary Risk-takers 4%, Unwary Risk-takers 4%, Sexual Function Problems 9%); six for women (Good Sexual Health 52%, Wary Risk-takers 2%, Unwary Risk-takers 7%, Low Interest 29%, Sexual Function Problems 7%, Highly Vulnerable 2%). Regardless of gender, Unwary Risk-takers reported lower STI/HIV risk perception and more condomless sex than Wary Risk-takers, but both were more likely to report STI diagnosis than Good Sexual Health classes. Highly Vulnerable women reported abortion, STIs and functional problems, and more sexual coercion than other women. Distinct socio-demographic profiles differentiated higher-risk classes from Good Sexual Health classes, with depression, alcohol/drug use, and early sexual debut widely-shared correlates of higher-risk classes. Females in higher-risk classes, and men with functional problems, evaluated their sex lives more negatively than those with Good Sexual Health. CONCLUSIONS: A greater prevalence and diversity of poor sexual health appears to exist among women than men in Britain, with more consistent effects on women's subjective sexual well-being. Shared health and lifestyle characteristics of higher-risk groups suggest widespread benefits of upstream interventions. Several groups could benefit from tailored interventions: men and women who underestimate their STI/HIV risk exposure, women distressed by low interest in sex, and women experiencing multiple adverse outcomes. Distinctive socio-demographic profiles should assist with identification and targeting

Characterization of Mycosphaerellaceae species associated with citrus greasy spot in Panama and Spain

[EN] Greasy spot of citrus, caused by Zasmidium citri-griseum (= Mycosphaerella citri), is widely distributed in the Caribbean Basin, inducing leaf spots, premature defoliation, and yield loss. Greasy spot-like symptoms were frequently observed in humid citrus-growing regions in Panama as well as in semi-arid areas in Spain, but disease aetiology was unknown. Citrus-growing areas in Panama and Spain were surveyed and isolates of Mycosphaerellaceae were obtained from citrus greasy spot lesions. A selection of isolates from Panama (n = 22) and Spain (n = 16) was assembled based on their geographical origin, citrus species, and affected tissue. The isolates were characterized based on multi-locus DNA (ITS and EF-1 alpha) sequence analyses, morphology, growth at different temperatures, and independent pathogenicity tests on the citrus species most affected in each country. Reference isolates and sequences were also included in the analysis. Isolates from Panama were identified as Z. citri-griseum complex, and others from Spain attributed to Amycosphaerella africana. Isolates of the Z. citri-griseum complex had a significantly higher optimal growth temperature (26.8 degrees C) than those of A. africana (19.3 degrees C), which corresponded well with their actual biogeographical range. The isolates of the Z. citri-griseum complex from Panama induced typical greasy spot symptoms in 'Valencia' sweet orange plants and the inoculated fungi were reisolated. No symptoms were observed in plants of the 'Ortanique' tangor inoculated with A. africana. These results demonstrate the presence of citrus greasy spot, caused by Z. citri-griseum complex, in Panama whereas A. africana was associated with greasy spot-like symptoms in Spain.Research was partially funded by 'Programa de Formacion de los INIA Iberoamerica' and INIA RTA2010-00105-00-00-FEDER to Vidal Aguilera Cogley.. We thank J. Martinez-Minaya (UV) for assistance with INLAAguilera-Cogley, VA.; Berbegal Martinez, M.; Català, S.; Collison Brentu, F.; Armengol Fortí, J.; Vicent Civera, A. (2017). Characterization of Mycosphaerellaceae species associated with citrus greasy spot in Panama and Spain. PLoS ONE. 12(12):1-19. https://doi.org/10.1371/journal.pone.0189585S1191212Crous, P. W., Summerell, B. A., Carnegie, A. J., Wingfield, M. J., Hunter, G. C., Burgess, T. I., … Groenewald, J. Z. (2009). Unravelling Mycosphaerella: do you believe in genera? Persoonia - Molecular Phylogeny and Evolution of Fungi, 23(1), 99-118. doi:10.3767/003158509x479487Mondal, S. N., & Timmer, L. W. (2006). Greasy Spot, a Serious Endemic Problem for Citrus Production in the Caribbean Basin. Plant Disease, 90(5), 532-538. doi:10.1094/pd-90-0532Whiteside, J. O. (1970). Etiology and Epidemiology of Citrus Greasy Spot. Phytopathology, 60(10), 1409. doi:10.1094/phyto-60-1409Huang, F., Groenewald, J. Z., Zhu, L., Crous, P. W., & Li, H. (2015). Cercosporoid diseases of Citrus. Mycologia, 107(6), 1151-1171. doi:10.3852/15-059Wellings, C. R. (1981). Pathogenicity of fungi associated with citrus greasy spot in New South Wales. Transactions of the British Mycological Society, 76(3), 495-499. doi:10.1016/s0007-1536(81)80080-0Marco, G. M. (1986). A Disease Similar to Greasy Spot but of Unknown Etiology on Citrus Leaves in Argentina. Plant Disease, 70(11), 1074a. doi:10.1094/pd-70-1074aVidal Aguilera-Cogley, & Antonio Vicent. (2015). FUNGAL DISEASES OF CITRUS IN PANAMA. Acta Horticulturae, (1065), 947-952. doi:10.17660/actahortic.2015.1065.118Honger J. Aetiology and importance of foliage diseases affecting citrus in the nursery at the Agricultural Research Station (ARS). PhD Thesis. Accra: University of Ghana; 2004.Vicent A, Álvarez A, León M, García-Jiménez J. Mycosphaerella sp. asociada a manchas foliares de cítricos en España. In: Proceedings of the 13th Congress of the Spanish Phytopathological Society. 2006; Murcia; Spain.Abdelfattah, A., Cacciola, S. O., Mosca, S., Zappia, R., & Schena, L. (2016). Analysis of the Fungal Diversity in Citrus Leaves with Greasy Spot Disease Symptoms. Microbial Ecology, 73(3), 739-749. doi:10.1007/s00248-016-0874-xQuaedvlieg, W., Binder, M., Groenewald, J. Z., Summerell, B. A., Carnegie, A. J., Burgess, T. I., & Crous, P. W. (2014). Introducing the Consolidated Species Concept to resolve species in the Teratosphaeriaceae. Persoonia - Molecular Phylogeny and Evolution of Fungi, 33(1), 1-40. doi:10.3767/003158514x681981Edgar, R. C. (2004). MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Research, 32(5), 1792-1797. doi:10.1093/nar/gkh340Darriba, D., Taboada, G. L., Doallo, R., & Posada, D. (2012). jModelTest 2: more models, new heuristics and parallel computing. Nature Methods, 9(8), 772-772. doi:10.1038/nmeth.2109Ronquist, F., Teslenko, M., van der Mark, P., Ayres, D. L., Darling, A., Höhna, S., … Huelsenbeck, J. P. (2012). MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice Across a Large Model Space. Systematic Biology, 61(3), 539-542. doi:10.1093/sysbio/sys029Rambaut A. FigTree v1. 4.0, a graphical viewer of phylogenetic trees. Edinburgh, Scotland: University of Edinburgh; 2016.Spiegelhalter, D. J., Best, N. G., Carlin, B. P., & van der Linde, A. (2002). Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 64(4), 583-639. doi:10.1111/1467-9868.00353Rue, H., Martino, S., & Chopin, N. (2009). Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 71(2), 319-392. doi:10.1111/j.1467-9868.2008.00700.xChristensen RH. Ordinal—regression models for ordinal data. R package version 2015.1–21. 2015. http://www.cran.r-project.org/package=ordinal/ Accessed 8 May 2017.Hunter, G. C., Wingfield, B. D., Crous, P. W., & Wingfield, M. J. (2006). A multi-gene phylogeny for species of Mycosphaerella occurring on Eucalyptus leaves. Studies in Mycology, 55, 147-161. doi:10.3114/sim.55.1.147Braun, U., & Urtiaga, R. (2013). New species and new records of cercosporoid hyphomycetes from Cuba and Venezuela (Part 2). Mycosphere, 4(2), 172-214. doi:10.5943/mycosphere/4/2/3Braun, U., Crous, P. W., & Nakashima, C. (2014). Cercosporoid fungi (Mycosphaerellaceae) 2. Species on monocots (Acoraceae to Xyridaceae, excluding Poaceae). IMA Fungus, 5(2), 203-390. doi:10.5598/imafungus.2014.05.02.04Aptroot A. Mycosphaerella and its anamorphs: conspectus of Mycosphaerella CBS Biodiversity Series 5. Utrecht: CBS-KNAW Fungal Biodiversity Centre; 2006.Crous, P. W., & Wingfield, M. J. (1996). Species of Mycosphaerella and Their Anamorphs Associated with Leaf Blotch Disease of Eucalyptus in South Africa. Mycologia, 88(3), 441. doi:10.2307/3760885Aguín, O., Sainz, M. J., Ares, A., Otero, L., & Pedro Mansilla, J. (2013). Incidence, severity and causal fungal species of Mycosphaerella and Teratosphaeria diseases in Eucalyptus stands in Galicia (NW Spain). Forest Ecology and Management, 302, 379-389. doi:10.1016/j.foreco.2013.03.021Maxwell, A., Dell, B., Neumeister-Kemp, H. G., & Hardy, G. E. S. J. (2003). Mycosphaerella species associated with Eucalyptus in south-western Australia: new species, new records and a key. Mycological Research, 107(3), 351-359. doi:10.1017/s0953756203007354Otero L, Aguín O, Mansilla J, Hunter G, Wingfield M. Identificación de especies de Mycosphaerella en Eucalyptus globulus y E. nitens en Galicia. In: Proceedings of the 13th Congress of the Spanish Phytopathological Society; 2006; Murcia, Spain.ZHAN, J., & McDONALD, B. A. (2011). Thermal adaptation in the fungal pathogen Mycosphaerella graminicola. Molecular Ecology, 20(8), 1689-1701. doi:10.1111/j.1365-294x.2011.05023.xPeel, M. C., Finlayson, B. L., & McMahon, T. A. (2007). Updated world map of the Köppen-Geiger climate classification. Hydrology and Earth System Sciences, 11(5), 1633-1644. doi:10.5194/hess-11-1633-200

Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?

Objective Very few studies have simultaneously examined incidence of the leading cancers in relation to socioeconomic status (SES) and race/ethnicity in populations including Hispanics and Asians. This study aims to describe SES disparity in cancer incidence within each of four major racial/ethnic groups (non-Hispanic white, black, Hispanic, and Asian/Pacific Islander) for five major cancer sites, including female breast cancer, colorectal cancer, cervical cancer, lung cancer, and prostate cancer. Methods Invasive cancers of the five major sites diagnosed from 1998 to 2002 (n = 376,158) in California were included in the study. Composite area-based SES measures were used to quantify SES level and to calculate cancer incidence rates stratified by SES. Relative index of inequality (RII) was generated to measure SES gradient of cancer incidence within each racial/ethnic group. Results Significant variations were detected in SES disparities across the racial/ethnic groups for all five major cancer sites. Female breast cancer and prostate cancer incidence increased with increased SES in all groups, with the trend strongest among Hispanics. Incidence of cervical cancer increased with decreased SES, with the largest gradient among non-Hispanic white women. Lung cancer incidence increased with decreased SES with the exception of Hispanic men and women, for whom SES gradient was in the opposite direction. For colorectal cancer, higher incidence was associated with lower SES in non-Hispanic whites but with higher SES in Hispanics and Asian/Pacific Islander women. Conclusions Examining SES disparity stratified by race/ethnicity enhances our understanding of the complex relationships between cancer incidence, SES, and race/ethnicity